Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons

Molecular and Cellular Endocrinology

Volumn 384, Issue 1-2, 2014, Pages 52-60

  Jayaraman, Anusha ^a   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

BDNF; Neuroprotection; Oestrogen receptor; Progestagen

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NEUROPROTECTIVE AGENT; NORETHISTERONE; NORETHISTERONE ACETATE; NORETYNODREL; NORGESTIMATE; SYNTHETIC PROGESTAGEN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BDNF GENE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ESTROGEN RECEPTOR ALPHA GENE; ESTROGEN RECEPTOR BETA GENE; ESTROGEN RECEPTOR GENE; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; MOLECULAR INTERACTION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

BDNF; NEUROPROTECTION; OESTROGEN RECEPTOR; PROGESTAGEN;

ANIMALS; CELL SURVIVAL; CEREBRAL CORTEX; EMBRYO, MAMMALIAN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NEURONS; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; PROGESTERONE CONGENERS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84893423967     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.01.003     Document Type: Article

References (61)

1. Aguirre C., Jayaraman A., Pike C., Baudry M. Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta. J. Neurochem. 2010, 115(5):1277-1287.
2. Aguirre C.C., Baudry M. Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices. Eur. J. Neurosci. 2009, 29(3):447-454.
3. Alkayed N.J., Murphy S.J., Traystman R.J., Hurn P.D., Miller V.M. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000, 31(1):161-168.
4. Allen T.K., Feng L., Grotegut C.A., Murtha A.P. Progesterone receptor membrane component 1 as the mediator of the inhibitory effect of progestins on cytokine-induced matrix metalloproteinase 9 activity in vitro. Reprod. Sci. 2013.
5. Baudry M., Bi X., Aguirre C. Progesterone-estrogen interactions in synaptic plasticity and neuroprotection. Neuroscience 2013, 239:280-294.
6. Bimonte-Nelson H., Nelson M.E., Granholm A.C. Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. NeuroReport 2004, 15(17):2659-2663.
7. Bottino M.C., Cerliani J.P., Rojas P., Giulianelli S., Soldati R., Mondillo C., Gorostiaga M.A., Pignataro O.P., Calvo J.C., Gutkind J.S., Panomwat A., Molinolo A.A., Luthy I.A., Lanari C. Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects. Breast Cancer Res. Treat. 2011, 126(3):621-636.
8. Brinton R.D., Thompson R.F., Foy M.R., Baudry M., Wang J., Finch C.E., Morgan T.E., Pike C.J., Mack W.J., Stanczyk F.Z., Nilsen J. Progesterone receptors: form and function in brain. Front. Neuroendocrinol. 2008, 29(2):313-339.
9. Bullock L.P., Bardin C.W. Androgenic, synandrogenic, and antiandrogenic actions of progestins. Ann. N. Y. Acad. Sci. 1977, 286:321-330.
10. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., Pike C.J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27(48):13357-13365.
11. Ciriza I., Carrero P., Frye C.A., Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 2006, 66(9):916-928.
12. Cordey M., Gundimeda U., Gopalakrishna R., Pike C.J. Estrogen activates protein kinase C in neurons: role in neuroprotection. J. Neurochem. 2003, 84(6):1340-1348.
13. De Nicola A.F., Labombarda F., Deniselle M.C., Gonzalez S.L., Garay L., Meyer M., Gargiulo G., Guennoun R., Schumacher M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol. 2009, 30(2):173-187.
14. Frye C.A., Vongher J.M. GABA(A), D1, and D5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis. Behav. Brain Res. 1999, 103(1):23-34.
15. Frye C.A., Vongher J.M. Progestins' rapid facilitation of lordosis when applied to the ventral tegmentum corresponds to efficacy at enhancing GABA(A)receptor activity. J. Neuroendocrinol. 1999, 11(11):829-837.
16. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 1998, 9(4):593-597.
17. Gonzalez Deniselle M.C., Garay L., Gonzalez S., Saravia F., Labombarda F., Guennoun R., Schumacher M., De Nicola A.F. Progesterone modulates brain-derived neurotrophic factor and choline acetyltransferase in degenerating Wobbler motoneurons. Exp. Neurol. 2007, 203(2):406-414.
18. Hussain R., El-Etr M., Gaci O., Rakotomamonjy J., Macklin W.B., Kumar N., Sitruk-Ware R., Schumacher M., Ghoumari A.M. Progesterone and Nestorone facilitate axon remyelination: a role for progesterone receptors. Endocrinology 2011, 152(10):3820-3831.
19. Irwin R.W., Yao J., Ahmed S.S., Hamilton R.T., Cadenas E., Brinton R.D. Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function. Endocrinology 2011, 152(2):556-567.
20. Jayaraman A., Carroll J.C., Morgan T.E., Lin S., Zhao L., Arimoto J.M., Murphy M.P., Beckett T.L., Finch C.E., Brinton R.D., Pike C.J. 17Beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology 2012, 153(11):5467-5479.
21. Jayaraman A., Pike C.J. Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J. Neuroendocrinol. 2009, 21(1):77-81.
22. Jodhka P.K., Kaur P., Underwood W., Lydon J.P., Singh M. The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology 2009, 150(7):3162-3168.
23. Kuhnz W., Fritzemeier K.H., Hegele-Hartung C., Krattenmacher R. Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor. Contraception 1995, 51(2):131-139.
24. Kumar N., Koide S.S., Tsong Y., Sundaram K. Nestorone: a progestin with a unique pharmacological profile. Steroids 2000, 65(10-11):629-636.
25. Labombarda F., Gonzalez S.L., Deniselle M.C., Vinson G.P., Schumacher M., De Nicola A.F., Guennoun R. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J. Neurochem. 2003, 87(4):902-913.
26. Liu L., Zhao L., She H., Chen S., Wang J.M., Wong C., McClure K., Sitruk-Ware R., Brinton R.D. Clinically relevant progestins regulate neurogenic and neuroprotective responses in vitro and in vivo. Endocrinology 2010, 151(12):5782-5794.
27. Liu M., Kelley M.H., Herson P.S., Hurn P.D. Neuroprotection of sex steroids. Minerva Endocrinol. 2010, 35(2):127-143.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
29. MacLusky N.J., McEwen B.S. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 1978, 274(5668):276-278.
30. Mannella P., Sanchez A.M., Giretti M.S., Genazzani A.R., Simoncini T. Oestrogen and progestins differently prevent glutamate toxicity in cortical neurons depending on prior hormonal exposure via the induction of neural nitric oxide synthase. Steroids 2009, 74(8):650-656.
31. Murphy D.D., Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J. Neurosci. 1996, 16(13):4059-4068.
32. Murphy D.D., Segal M. Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology 2000, 72(3):133-143.
33. Nguyen T.V., Jayaraman A., Quaglino A., Pike C.J. Androgens selectively protect against apoptosis in hippocampal neurones. J. Neuroendocrinol. 2010, 22(9):1013-1022.
34. Nilsen J., Brinton R.D. Impact of progestins on estradiol potentiation of the glutamate calcium response. NeuroReport 2002, 13(6):825-830.
35. Nilsen J., Diaz Brinton R. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc. Natl. Acad. Sci. USA 2003, 100(5):2842-2847.
36. Nilsen J., Morales A., Brinton R.D. Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol. Endocrinol. 2006, 22(7):355-361.
37. Palmer R., Guillon G., Pasquier F., Proust-Perrault J. Clinical and biochemical study of 37 cases of endocrine sterility, with corpus luteum estrogenic deficiency in Jayle's dynamic test, treated by HMG-O in the preovulation phase. Gynecol. Obstet. (Paris) 1969, 68(1):51-58.
38. Rhodes M.E., Frye C.A. Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia 2004, 45(12):1531-1538.
39. Roof R.L., Duvdevani R., Braswell L., Stein D.G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 1994, 129(1):64-69.
40. Rosario E.R., Ramsden M., Pike C.J. Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res. 2006, 1099(1):206-210.
41. Ruan X., Neubauer H., Yang Y., Schneck H., Schultz S., Fehm T., Cahill M.A., Seeger H., Mueck A.O. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012, 15(5):467-472.
42. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
43. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3(6):1101-1108.
44. Schreiber J.R., Hsueh A.J., Baulieu E.E. Binding of the anti-progestin RU-486 to rat ovary steroid receptors. Contraception 1983, 28(1):77-85.
45. Schumacher M., Guennoun R., Ghoumari A., Massaad C., Robert F., El-Etr M., Akwa Y., Rajkowski K., Baulieu E.E. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr. Rev. 2007, 28(4):387-439.
46. Schumacher M., Guennoun R., Stein D.G., De Nicola A.F. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol. Ther. 2007, 116(1):77-106.
47. Schumacher M., Sitruk-Ware R., De Nicola A.F. Progesterone and progestins: neuroprotection and myelin repair. Curr. Opin. Pharmacol. 2008, 8(6):740-746.
48. Shirk R.A., Zhang Z., Winneker R.C. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat. J. Steroid Biochem. Mol. Biol. 2005, 94(4):361-368.
49. Shughrue P.J., Lane M.V., Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology 1997, 138(12):5476-5484.
50. Shughrue P.J., Stumpf W.E., Elger W., Schulze P.E., Sar M. Progestin receptor cells in mouse cerebral cortex during early postnatal development: a comparison with preoptic area and central hypothalamus using autoradiography with [125I] progestin. Brain Res. Dev. Brain Res. 1991, 59(2):143-155.
51. Sitruk-Ware R. Approval of mifepristone (RU 486) in Europe. Zentralbl. Gynakol. 2000, 122(5):241-247.
52. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids 2000, 65(10-11):651-658.
53. Sitruk-Ware R. Hormonal replacement therapy. Rev. Endocrinol. Metab. Disord. 2002, 3(3):243-256.
54. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause 2002, 9(1):6-15.
55. Sitruk-Ware R. Pharmacological profile of progestins. Maturitas 2004, 47(4):277-283.
56. Stanczyk F.Z., Hapgood J.P., Winer S., Mishell D.R. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr. Rev. 2013, 34(2):171-208.
57. Stein D.G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 2008, 57(2):386-397.
58. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin. Investig. Drugs 2010, 19(7):847-857.
59. Vereide A.B., Kaino T., Sager G., Arnes M., Orbo A. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia. Gynecol. Oncol. 2006, 101(2):214-223.
60. Wiegratz I., Kuhl H. Progestogen therapies: differences in clinical effects?. Trends Endocrinol. Metab. 2004, 15(6):277-285.
61. Zuloaga D.G., Yahn S.L., Pang Y., Quihuis A.M., Oyola M.G., Reyna A., Thomas P., Handa R.J., Mani S.K. Distribution and estrogen regulation of membrane progesterone receptor-beta in the female rat brain. Endocrinology 2012, 153(9):4432-4443.